March 2024 in “EMBO molecular medicine” Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.
December 2013 in “American journal of transplantation” The patient improved after antiviral treatment for a viral infection.
52 citations
,
January 2022 in “Current Research in Pharmacology and Drug Discovery” New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.
9 citations
,
November 2012 in “Hepatology Research” A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.
42 citations
,
April 2021 in “Pharmaceuticals” In response to the COVID-19 pandemic, researchers conducted a study to identify FDA-approved drugs that could be repurposed as antiviral treatments against SARS-CoV-2. They employed a hierarchical in silico/in vitro screening method, which combined virtual and biological screening to efficiently identify host-directed therapies. The study focused on host-based targets related to viral entry and led to the identification of five potentially repurposable drugs: cepharantine, clofazimine, metergoline, imatinib, and efloxate, which showed potential in interfering with viral entry.